ProfAnnette Byrne

Professor

Physiology and Medical Physics

  • Professor
    Physiology and Medical Physics
  • Royal College of Surgeons in Ireland, Graduate Entry Medicine (GEM), RCSI Mercer Building (Entrance on Noel Purcell Walk), Dublin, 2, Ireland

BIOGRAPHY

Prof Annette Byrne is Professor (Physiology) and Head of the RCSI Precision Cancer Medicine (PCM) Group which was established in 2008 at the Royal College of Surgeons in Ireland.

 

In 1999, having gained a PhD in Cell Biology at the University of York, UK, Prof Byrne was awarded the John Kerner fellowship in Gynaecologic Oncology from the University of California, San Francisco. During this period she was engaged in the elucidation of novel angiogenesis targets involved in the development of ovarian cancer, as well as interrogating the in vivo activity of novel therapeutics. Subsequently, Prof Byrne was recruited as Scientist by Pharmacyclics LLC (Sunnyvale, California) to investigate the mechanism of action of a new class of radiation/ chemotherapy under clinical development. In 2003 Prof Byrne relocated to New York where she was employed as Senior Scientist in Angion Biomedica Corp, whose main focus was developing therapeutics which manipulated angiogenesis signalling pathways.

 

Prof Byrne returned to Ireland in 2005 to the position of Principal Investigator at University College Dublin's Conway Institute. During this engagement she was instrumental in establishing Ireland's first comprehensive Tumour Xenograft Facility and translational Pre-clinical Imaging Centre. Prof Byrne was recruited to the Royal College of Surgeons in Ireland in 2008 as tenured Lecturer (Physiology) and Principal Investigator, RCSI Centre for Systems Medicine & Dept of Physiology and Medical Physics. Prof Byrne was promoted to Snr Lecturer in 2013, to Associate Professor in 2017 and to Full Professor in 2019.

 

In 2025 Prof Byrne was elected as a Member of the Royal Irish Academy.


For more information please visit www.precisioncancermedicinegroup.com

ACADEMIC POSITIONS

  • 'John Kerner' Gynaecologic Oncology Fellow
    University of California, San Francisco, USA1 Jan 1999 - 1 Jan 2001
  • Scientist
    Pharmacyclics Inc., Sunnyvale, California, USA1 Jan 2001 - 1 Jan 2003
  • Senior Scientist
    Angion Biomedica Corp., Manhasset, New York, USA1 Jan 2003 - 1 Jan 2005
  • Principal Investigator
    University College Dublin1 Jan 2005 - 1 Jan 2008
  • (Honorary) Visiting Lecturer
    University College Dublin1 Jan 2010 - 1 Jan 2015
  • Consultant Pre-Clinical/Oncology
    Guidepoint Global Advisors, NY1 Jan 2005
  • Principle Investigator
    Royal College of Surgeons in Ireland1 Jan 2008
  • Tenured Lecturer - Physiology
    Royal College of Surgeons in Ireland1 Jan 2008
  • Associate Professor
    Royal College of Surgeons Ireland, Ireland1 Jan 2017 - 30 Sep 2019
  • Associate Conway Fellow
    University College Dublin, Ireland1 Jan 2015 - 30 Sep 2019
  • Professor
    Royal College of Surgeons in Ireland, Dublin, Ireland1 Oct 2019
  • Visiting Full Professor
    University College Dublin, Dublin, Ireland1 Oct 2019 - 30 Sep 2024

DEGREES

  • BSc Hons, Human Physiology
    University College Cork25 Dec 1996
  • PhD, Cell Biology
    University of York, UK25 Dec 1999

RESEARCH SUB-AREAS

  • Angiogenesis
  • Biomaterials
  • Brain Cancer
  • Colorectal Cancer
  • Diagnostic Imaging
  • Drug development
  • Drug resistance
  • Genomics
  • Proteomics
  • Systems Biology

SUSTAINABLE DEVELOPMENT GOALS (UNSDGS)

  • 3 Good Health and Well Being

RESEARCH CLUSTERS